Compare COCP & GXAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | COCP | GXAI |
|---|---|---|
| Founded | 2006 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.6M | 13.5M |
| IPO Year | 2011 | 2022 |
| Metric | COCP | GXAI |
|---|---|---|
| Price | $1.12 | $1.17 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | 118.8K | ★ 276.1K |
| Earning Date | 05-15-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 54.65 | ★ 71.35 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $12,712,091.00 | $1,933,030.00 |
| Revenue This Year | N/A | $271.23 |
| Revenue Next Year | N/A | $36.32 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 47901.74 |
| 52 Week Low | $0.86 | $1.02 |
| 52 Week High | $2.19 | $2.96 |
| Indicator | COCP | GXAI |
|---|---|---|
| Relative Strength Index (RSI) | 37.96 | 45.40 |
| Support Level | $1.00 | $1.04 |
| Resistance Level | $1.27 | $1.31 |
| Average True Range (ATR) | 0.08 | 0.06 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 12.50 | 46.47 |
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).
Gaxos.AI Inc is a technology company focused on reshaping the way people interact with artificial intelligence across everyday life and high-impact industries. It is engaged in building a portfolio of AI-powered solutions designed to make advanced technology more practical, accessible, and transformative. The company's portfolio spans defense, health and wellness, entertainment, and productivity - bringing intelligent tools to markets where innovation can drive meaningful real-world outcomes. It operates as a single operating segment technology-based company that is developing applications aimed at redefining the way it utilizes artificial intelligence (AI) to optimize the user experience.